Retatrutide, a experimental dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor , is exhibiting promising results in early clinical trials . Ongoing https://listbell.com/story11265937/retatrutide-emerging-studies-and-potential-medical-applications